Drug Delivery Infusion Systems-Medical Devices Pipeline Assessment, 2016

Drug Delivery Infusion Systems-Medical Devices Pipeline Assessment, 2016


  • Products Id :- GDME0209EPD
  • |
  • Pages: 148
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Drug Delivery Infusion Systems-Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, "Drug Delivery Infusion Systems-Medical Devices Pipeline Assessment, 2016" provides an overview of Drug Delivery Infusion Systems currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Drug Delivery Infusion Systems pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Drug Delivery Infusion Systems under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Drug Delivery Infusion Systems and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment / industry

Reasons To Buy

The report enables you to-

Formulate significant competitor information, analysis, and insights to improve R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Drug Delivery Infusion Systems under development

Develop market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

In-depth analysis of the product's current stage of development, territory and estimated launch date



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 7

1.2 List of Figures 11

2 Introduction 12

2.1 Drug Delivery Infusion Systems Overview 12

3 Products under Development 14

3.1 Drug Delivery Infusion Systems-Pipeline Products by Stage of Development 14

3.2 Drug Delivery Infusion Systems-Pipeline Products by Segment 15

3.3 Drug Delivery Infusion Systems-Pipeline Products by Territory 16

3.4 Drug Delivery Infusion Systems-Pipeline Products by Regulatory Path 17

3.5 Drug Delivery Infusion Systems-Pipeline Products by Estimated Approval Date 18

3.6 Drug Delivery Infusion Systems-Ongoing Clinical Trials 19

4 Drug Delivery Infusion Systems-Pipeline Products under Development by Companies 20

4.1 Drug Delivery Infusion Systems-Pipeline Products by Stage of Development 20

4.2 Drug Delivery Infusion Systems-Pipeline Products by Stage of Development 22

5 Drug Delivery Infusion Systems Companies and Product Overview 24

5.1 410 Medical Innovation, LLC Company Overview 24

5.1.1 410 Medical Innovation, LLC Pipeline Products & Ongoing Clinical Trials Overview 24

5.2 Acuros GmbH Company Overview 25

5.2.1 Acuros GmbH Pipeline Products & Ongoing Clinical Trials Overview 25

5.3 AktiVax Inc. Company Overview 26

5.3.1 AktiVax Inc. Pipeline Products & Ongoing Clinical Trials Overview 26

5.4 Alnylam Pharmaceuticals, Inc. Company Overview 27

5.4.1 Alnylam Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27

5.5 Anesthesia Safety Products, LLC Company Overview 29

5.5.1 Anesthesia Safety Products, LLC Pipeline Products & Ongoing Clinical Trials Overview 29

5.6 AngioDynamics, Inc. Company Overview 30

5.6.1 AngioDynamics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 30

5.7 Automedics Medical Systems Company Overview 34

5.7.1 Automedics Medical Systems Pipeline Products & Ongoing Clinical Trials Overview 34

5.8 Baxter International Inc. Company Overview 35

5.8.1 Baxter International Inc. Pipeline Products & Ongoing Clinical Trials Overview 35

5.9 BioCardia, Inc. Company Overview 36

5.9.1 BioCardia, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36

5.10 Debiotech S.A. Company Overview 38

5.10.1 Debiotech S.A. Pipeline Products & Ongoing Clinical Trials Overview 38

5.11 Delpor, Inc. Company Overview 40

5.11.1 Delpor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40

5.12 Edwards Lifesciences Corporation Company Overview 42

5.12.1 Edwards Lifesciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 42

5.13 Eksigent Technologies, LLC Company Overview 43

5.13.1 Eksigent Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 43

5.14 Eli Lilly and Company Company Overview 45

5.14.1 Eli Lilly and Company Pipeline Products & Ongoing Clinical Trials Overview 45

5.15 Flowonix Medical, Inc. Company Overview 47

5.15.1 Flowonix Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47

5.16 FluidSynchrony, LLC Company Overview 48

5.16.1 FluidSynchrony, LLC Pipeline Products & Ongoing Clinical Trials Overview 48

5.17 Fluonic, Inc. Company Overview 49

5.17.1 Fluonic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49

5.18 Fresenius Kidney Care Company Overview 50

5.18.1 Fresenius Kidney Care Pipeline Products & Ongoing Clinical Trials Overview 50

5.19 Imagnus Biomedical Inc. Company Overview 51

5.19.1 Imagnus Biomedical Inc. Pipeline Products & Ongoing Clinical Trials Overview 51

5.20 Innovfusion Pte. Ltd. Company Overview 52

5.20.1 Innovfusion Pte. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 52

5.21 Intarcia Therapeutics, Inc. Company Overview 55

5.21.1 Intarcia Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55

5.22 IRadimed Corporation Company Overview 59

5.22.1 IRadimed Corporation Pipeline Products & Ongoing Clinical Trials Overview 59

5.23 Ivenix, Inc. Company Overview 61

5.23.1 Ivenix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 61

5.24 LifeMedix, LLC Company Overview 63

5.24.1 LifeMedix, LLC Pipeline Products & Ongoing Clinical Trials Overview 63

5.25 Lynntech, Inc. Company Overview 64

5.25.1 Lynntech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 64

5.26 Medallion Therapeutics, Inc. Company Overview 65

5.26.1 Medallion Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 65

5.27 Medical Device Creations Ltd. Company Overview 66

5.27.1 Medical Device Creations Ltd. Pipeline Products & Ongoing Clinical Trials Overview 66

5.28 MedPrime Technologies Pvt. Ltd. Company Overview 67

5.28.1 MedPrime Technologies Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 67

5.29 Mercator MedSystems, Inc. Company Overview 68

5.29.1 Mercator MedSystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 68

5.30 Nano Precision Medical Company Overview 72

5.30.1 Nano Precision Medical Pipeline Products & Ongoing Clinical Trials Overview 72

5.31 NexGen Medical Systems, Inc. Company Overview 73

5.31.1 NexGen Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 73

5.32 Nipro Corporation Company Overview 74

5.32.1 Nipro Corporation Pipeline Products & Ongoing Clinical Trials Overview 74

5.33 Owen Mumford Limited Company Overview 76

5.33.1 Owen Mumford Limited Pipeline Products & Ongoing Clinical Trials Overview 76

5.34 Pavmed Inc Company Overview 77

5.34.1 Pavmed Inc Pipeline Products & Ongoing Clinical Trials Overview 77

5.35 PRO-IV Medical Ltd. Company Overview 78

5.35.1 PRO-IV Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 78

5.36 Ratio, Inc. Company Overview 81

5.36.1 Ratio, Inc. Pipeline Products & Ongoing Clinical Trials Overview 81

5.37 Rice University Company Overview 82

5.37.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview 82

5.38 SteadyMed Therapeutics, Inc. Company Overview 83

5.38.1 SteadyMed Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 83

5.39 StnDrd Infusion Corporation Company Overview 85

5.39.1 StnDrd Infusion Corporation Pipeline Products & Ongoing Clinical Trials Overview 85

5.40 Tel Aviv University Company Overview 87

5.40.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 87

5.41 Terumo Corporation Company Overview 88

5.41.1 Terumo Corporation Pipeline Products & Ongoing Clinical Trials Overview 88

5.42 ToucheMedical Ltd. Company Overview 90

5.42.1 ToucheMedical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 90

5.43 Unilife Corporation Company Overview 91

5.43.1 Unilife Corporation Pipeline Products & Ongoing Clinical Trials Overview 91

5.44 University of Minnesota Company Overview 93

5.44.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 93

5.45 University of Southern California Company Overview 95

5.45.1 University of Southern California Pipeline Products & Ongoing Clinical Trials Overview 95

6 Drug Delivery Infusion Systems-Recent Developments 96

6.1 Jun 16, 2016: Data Show Sigma Spectrum Infusion System Users Achieved 97 Percent Drug Library Compliance Rate within the First Month of Implementation 96

6.2 Jun 14, 2016: IRADIMED Announces Election of Roger Susi as Chairman of the Board 96

6.3 Jun 13, 2016: Aarti Shah named chief information officer 97

6.4 Jun 12, 2016: Intarcia Presents FREEDOM-2 Trial Results in Type 2 Diabetes Demonstrating Clinically Meaningful Superiority and Sustained Glucose Control and Weight Reduction for ITCA 650 vs. Januvia: Oral Presentation at ADA 76th Scientific Sessions 97

6.5 Jun 09, 2016: IRADIMED Provides Regulatory Update 99

6.6 Jun 07, 2016: Intarcia Announces Branding of the Medici Drug Delivery System- A Platform of Technologies Key to Advancing its Pipeline of Once-Yearly Peptide and Antibody Fragment-Based Therapeutics in Poorly Controlled Chronic Diseases 100

6.7 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 100

6.8 Jun 03, 2016: Autostart Burette Listed Through Qld Health Tender 101

6.9 Jun 01, 2016: Phillips-Medisize Acquires Medicom Innovation Partner 101

6.10 Jun 01, 2016: Flowonix Medical Raises USD10.5 Million in Venture Financing 102

6.11 Jun 01, 2016: Flowonix Medical Secures USD5 Million in Venture Debt Financing 102

6.12 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 102

6.13 May 24, 2016: Pyng Medical Reports Second Quarter Fiscal 2016 Results 104

6.14 May 24, 2016: Lilly Details Robust R&D Pipeline to Investment Community 105

6.15 May 23, 2016: Real World Data In Europe Show Majority Of Diabetic Macular Edema Patients Gain Or Maintain Vision With Iluvien At 12 Months 106

6.16 May 23, 2016: Unilife Announces Receipt of Deficiency Letter from NASDAQ 107

6.17 May 18, 2016: Study Finds 90 Percent of Pump Programming Events for High-Alert Infusion Medications are Dose Adjustments 107

6.18 May 18, 2016: Flowonix Medical Appoints Larry Heaton as CEO 108

6.19 May 18, 2016: Repro Med Systems Posts Fourth Quarter and Fiscal Year 2016 Results and Announces New Member of the Board of Directors 109

6.20 May 16, 2016: B. Braun to Showcase Its Innovative Synchronized Intelligence Infusion Platform at AACN 110

6.21 May 13, 2016: ConvaTec Healthcare May Raise USD1 Billion in IPO 110

6.22 May 13, 2016: PAVmed Announces First Quarter 2016 Financial Results 111

6.23 May 11, 2016: Teleflex Raises USD400 Million in Public Offering of 4.875% Notes Due 2026 111

6.24 May 11, 2016: Steadymed Provides Corporate Update And Reports First Quarter 2016 Financial Results 111

6.25 May 10, 2016: B. Braun Medical Calls for ECRI Institute to Establish a Scientific, Protocol-Driven Methodology for Evaluating Infusion Pumps 112

6.26 May 09, 2016: Baxter Highlights Business Strategies and Innovation at 2016 Investor Conference 113

6.27 May 06, 2016: Alimera Sciences' ILUVIEN Data Presented At 2016 ARVO 114

6.28 May 06, 2016: Intarcia Announces Successful Cardiovascular Safety Results in Phase 3 FREEDOM-CVO Trial for ITCA 650, an Investigational Therapy for Type 2 Diabetes 115

6.29 May 03, 2016: Strong start into the year-Double-digit earnings growth in constant currency-Fresenius confirms Group guidance for 2016 116

6.30 Apr 29, 2016: IRADIMED Announces First Quarter 2016 Financial Results 118

6.31 Apr 15, 2016: InfuSystem to Acquire Infusion Pump Assets from InfusAID 119

6.32 Apr 08, 2016: Fresenius Vamed lays foundation stone for new university hospital building 120

6.33 Apr 01, 2016: IRADIMED Provides Regulatory Update 120

6.34 Mar 29, 2016: Hicks Thomas Represents EMED Technologies Seeking Injunction against RMS Medical Products for Infusion Devices FDA Warns Are Adulterated and Misbranded 120

6.35 Mar 15, 2016: Zyno Medical to Feature Z-800F Set Based Anti-Free-Flow IV Pump at NHIA 121

6.36 Mar 09, 2016: Repro Med Systems Responds to FDA Warning Letter 121

6.37 Feb 26, 2016: Zyno Medical to Feature ZynoFlo Integrated Infusion System at ACCC 121

6.38 Feb 26, 2016: Zyno Medical to Feature Z-800WF IV Infusion Pump at ACCC 122

6.39 Feb 24, 2016: Alaris System Named 2015 Best In KLAS for Smart Pumps 122

6.40 Feb 24, 2016: Outstanding 2015 financial results-25% dividend increase proposed-Positive outlook for 2016-New mid-term growth targets 123

6.41 Feb 24, 2016: Aetna and Roxborough Memorial Hospital Agree to Three-Year Contract 127

6.42 Feb 09, 2016: Dr. Seema Kumbhat Named Fresenius Kabi USA Medical Director 128

6.43 Feb 05, 2016: IRADIMED Announces Fourth Quarter 2015 Financial Results 128

6.44 Jan 21, 2016: Mercator MedSystems Announces First Patient Enrolled in Below the Knee Clinical Trial 129

6.45 Jan 20, 2016: LifeFlow Rapid Infuser Receives Innovation Award at Pediatrics 2040 Meeting 130

6.46 Jan 13, 2016: Pfizer May Sell Infusion Pump Business of Hospira 130

6.47 Jan 11, 2016: IRADIMED Announces 2016 Annual and First Quarter Financial Guidance 131

6.48 Jan 06, 2016: Ivenix Appoints MedTech Industry Veteran Stuart A. Randle as Chief Executive Officer 131

6.49 Dec 10, 2015: IRADIMED Updates Status of 510(k) Submission 132

6.50 Dec 02, 2015: Surefire Medical Raises USD15 Million in Series C Financing 132

6.51 Nov 05, 2015: Surefire Medical Raises Additional USD4 Million in Venture Financing 132

6.52 Nov 03, 2015: IRadimed Plans to Raise up to USD40 Million in Public Offering of Shares 133

6.53 Nov 02, 2015: Flowonix Medical and Connecticut Pain Care Announce the First Implant of the Prometra II Pump in Danbury, CT 133

6.54 Oct 30, 2015: IRADIMED Announces Third Quarter 2015 Financial Results 133

6.55 Oct 30, 2015: IRADIMED Announces Dismissal of Appeal 134

6.56 Oct 28, 2015: SteadyMed Announces Positive Clinical Study Results in Support of SMT-201 for the Treatment of Post Surgical Pain in the Home Setting 134

6.57 Oct 23, 2015: Edwards Lifesciences Enters into Agreement with CareFusion 135

6.58 Oct 08, 2015: Smiths Medical Awarded Contract by Novation 135

6.59 Oct 08, 2015: Bespak Launches New Brand Identity To The Market 136

6.60 Oct 05, 2015: Medicom receives the growth award-Borsen Gazelle 2015 136

6.61 Sep 25, 2015: Surefire Medical Introduces New Precision Infusion System 136

6.62 Sep 22, 2015: B. Braun Receives FDA Clearance for Infusomat Space Pump 137

6.63 Sep 03, 2015: pSivida CEO Invited to Speak at Surfaces in BioMaterials Foundation's BioInterface 2015 Annual Symposium 138

6.64 Sep 01, 2015: Surefire Medical Receives FDA Clearance for Precision Direct-to-Tumor Embolization Device 138

6.65 Aug 27, 2015: Hospira Announces First Installation of Plum 360 Infusion System With Hospira MedNet 138

6.66 Aug 11, 2015: Command Medical Products Announces Promotion to Vice President 139

6.67 Jul 31, 2015: Symbiq Infusion System by Hospira: FDA Safety Communication-Cybersecurity Vulnerabilities 140

6.68 Jul 30, 2015: IRADIMED Announces Second Quarter 2015 Financial Results 140

6.69 Jul 29, 2015: Hospira Reports Second-Quarter 2015 Results 141

6.70 Jul 29, 2015: Fresenius Medical Care Reports Second Quarter 2015 Results And Confirms Guidance For Full Year 2015 142

6.71 Jul 16, 2015: Novo Nordisk Receives FDA Approval for FlexPro PenMate for People with Growth Hormone-Related Disorders 143

6.72 Jul 08, 2015: MicroPort Lifesciences Attends Diabetes and Gonadal Disorders Meeting to Promote La Fenice 144

7 Appendix 145

7.1 Methodology 145

7.2 About GlobalData 147

7.3 Contact Us 148

7.4 Disclaimer 148

1.2 List of Figures

Figure 1: Drug Delivery Infusion Systems-Pipeline Products by Stage of Development 14

Figure 2: Drug Delivery Infusion Systems-Pipeline Products by Segment 15

Figure 3: Drug Delivery Infusion Systems-Pipeline Products by Territory 16

Figure 4: Drug Delivery Infusion Systems-Pipeline Products by Regulatory Path 17

Figure 5: Drug Delivery Infusion Systems-Pipeline Products by Estimated Approval Date 18

Figure 6: Drug Delivery Infusion Systems-Ongoing Clinical Trials 19

1.1 List of Tables

Table 1: Drug Delivery Infusion Systems-Pipeline Products by Stage of Development 14

Table 2: Drug Delivery Infusion Systems-Pipeline Products by Segment 15

Table 3: Drug Delivery Infusion Systems-Pipeline Products by Territory 16

Table 4: Drug Delivery Infusion Systems-Pipeline Products by Regulatory Path 17

Table 5: Drug Delivery Infusion Systems-Pipeline Products by Estimated Approval Date 18

Table 6: Drug Delivery Infusion Systems-Ongoing Clinical Trials 19

Table 7: Drug Delivery Infusion Systems Companies-Pipeline Products by Stage of Development 20

Table 8: Drug Delivery Infusion Systems-Pipeline Products by Stage of Development 22

Table 9: 410 Medical Innovation, LLC Pipeline Products & Ongoing Clinical Trials Overview 24

Table 10: LifeFlow Rapid Infusion System-Product Status 24

Table 11: LifeFlow Rapid Infusion System-Product Description 24

Table 12: Acuros GmbH Pipeline Products & Ongoing Clinical Trials Overview 25

Table 13: Disposable Micropump-Product Status 25

Table 14: Disposable Micropump-Product Description 25

Table 15: AktiVax Inc. Pipeline Products & Ongoing Clinical Trials Overview 26

Table 16: Immunoject-Product Status 26

Table 17: Immunoject-Product Description 26

Table 18: Alnylam Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27

Table 19: ALN-HTT Infusion System-Product Status 27

Table 20: ALN-HTT Infusion System-Product Description 28

Table 21: Anesthesia Safety Products, LLC Pipeline Products & Ongoing Clinical Trials Overview 29

Table 22: FloStat Infusion Pump System-Product Status 29

Table 23: FloStat Infusion Pump System-Product Description 29

Table 24: AngioDynamics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 30

Table 25: BioFlo Portline Line Extension-Product Status 30

Table 26: BioFlo Portline Line Extension-Product Description 31

Table 27: Next Generation BioFlo Port-Product Status 31

Table 28: Next Generation BioFlo Port-Product Description 31

Table 29: Power Injectable Port-Product Status 32

Table 30: Power Injectable Port-Product Description 32

Table 31: Smart Port-Dual-Product Status 32

Table 32: Smart Port-Dual-Product Description 33

Table 33: Automedics Medical Systems Pipeline Products & Ongoing Clinical Trials Overview 34

Table 34: AutoHep System-Product Status 34

Table 35: AutoHep System-Product Description 34

Table 36: Baxter International Inc. Pipeline Products & Ongoing Clinical Trials Overview 35

Table 37: Infusion Pump-Product Status 35

Table 38: Infusion Pump-Product Description 35

Table 39: BioCardia, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36

Table 40: Helix Transendocardial Delivery System-Product Status 36

Table 41: Helix Transendocardial Delivery System-Product Description 37

Table 42: Debiotech S.A. Pipeline Products & Ongoing Clinical Trials Overview 38

Table 43: MIP Device-Product Status 38

Table 44: MIP Device-Product Description 39

Table 45: Delpor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40

Table 46: Delpor Microfabricated Nanopore Device-Product Status 40

Table 47: Delpor Microfabricated Nanopore Device-Product Description 41

Table 48: Edwards Lifesciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 42

Table 49: Integrated Semi-Closed Loop System-Product Status 42

Table 50: Integrated Semi-Closed Loop System-Product Description 42

Table 51: Eksigent Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 43

Table 52: External Drug Delivery System-Product Status 43

Table 53: External Drug Delivery System-Product Description 43

Table 54: Implantable Drug Delivery System-Product Status 44

Table 55: Implantable Drug Delivery System-Product Description 44

Table 56: Eli Lilly and Company Pipeline Products & Ongoing Clinical Trials Overview 45

Table 57: Drug Delivery System-Parkinson's Disease-Product Status 45

Table 58: Drug Delivery System-Parkinson's Disease-Product Description 46

Table 59: Flowonix Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47

Table 60: Implanted Drug Delivery System-Product Status 47

Table 61: Implanted Drug Delivery System-Product Description 47

Table 62: FluidSynchrony, LLC Pipeline Products & Ongoing Clinical Trials Overview 48

Table 63: FluidSync Pump-Product Status 48

Table 64: FluidSync Pump-Product Description 48

Table 65: Fluonic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49

Table 66: SURE+-Product Status 49

Table 67: SURE+-Product Description 49

Table 68: Fresenius Kidney Care Pipeline Products & Ongoing Clinical Trials Overview 50

Table 69: Intravenous 2008MeDS-Product Status 50

Table 70: Intravenous 2008MeDS-Product Description 50

Table 71: Imagnus Biomedical Inc. Pipeline Products & Ongoing Clinical Trials Overview 51

Table 72: DeltaFlow Infusion Regulator-Product Status 51

Table 73: DeltaFlow Infusion Regulator-Product Description 51

Table 74: Innovfusion Pte. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 52

Table 75: DIVA-Product Status 52

Table 76: DIVA-Product Description 52

Table 77: EPIVA-Product Status 53

Table 78: EPIVA-Product Description 53

Table 79: INTRAVA-Product Status 54

Table 80: INTRAVA-Product Description 54

Table 81: Intarcia Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55

Table 82: ITCA 638-Product Status 55

Table 83: ITCA 638-Product Description 56

Table 84: ITCA 650 Osmotic Pump-Product Status 56

Table 85: ITCA 650 Osmotic Pump-Product Description 57

Table 86: ITCA 880-Product Status 57

Table 87: ITCA 880-Product Description 58

Table 88: IRadimed Corporation Pipeline Products & Ongoing Clinical Trials Overview 59

Table 89: MRidium 3860+ MRI IV Pump-Product Status 59

Table 90: MRidium 3860+ MRI IV Pump-Product Description 60

Table 91: Ivenix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 61

Table 92: Next-Generation Infusion Management System-Product Status 61

Table 93: Next-Generation Infusion Management System-Product Description 62

Table 94: LifeMedix, LLC Pipeline Products & Ongoing Clinical Trials Overview 63

Table 95: STATfusion-Product Status 63

Table 96: STATfusion-Product Description 63

Table 97: Lynntech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 64

Table 98: Disposable Drug Infusion Pump-Product Status 64

Table 99: Disposable Drug Infusion Pump-Product Description 64

Table 100: Medallion Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 65

Table 101: Medallion Infusion System-Product Status 65

Table 102: Medallion Infusion System-Product Description 65

Table 103: Medical Device Creations Ltd. Pipeline Products & Ongoing Clinical Trials Overview 66

Table 104: Infusion Pump-Product Status 66

Table 105: Infusion Pump-Product Description 66

Table 106: MedPrime Technologies Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 67

Table 107: InfuCheck-Product Status 67

Table 108: InfuCheck-Product Description 67

Table 109: Mercator MedSystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 68

Table 110: Bullfrog Micro-Infusion Device-Below The Knee-Product Status 68

Table 111: Bullfrog Micro-Infusion Device-Below The Knee-Product Description 69

Table 112: Mercator MedSystems, Inc.-Ongoing Clinical Trials Overview 70

Table 113: Bullfrog Micro-Infusion Device-Below The Knee-Lower-limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Atherectomy (ATX)-based Revascularization (LIMBO-ATX) 71

Table 114: Bullfrog Micro-Infusion Device-Below The Knee-Lower-limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis after Percutaneous Transluminal Angioplasty Revascularization (LIMBO-PTA) 71

Table 115: Nano Precision Medical Pipeline Products & Ongoing Clinical Trials Overview 72

Table 116: Nano Portal Capsule-Product Status 72

Table 117: Nano Portal Capsule-Product Description 72

Table 118: NexGen Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 73

Table 119: PeriCATH-Product Status 73

Table 120: PeriCATH-Product Description 73

Table 121: Nipro Corporation Pipeline Products & Ongoing Clinical Trials Overview 74

Table 122: Pump For Venous Anesthesia Infusion-Product Status 74

Table 123: Pump For Venous Anesthesia Infusion-Product Description 75

Table 124: Owen Mumford Limited Pipeline Products & Ongoing Clinical Trials Overview 76

Table 125: UniSafe-Product Status 76

Table 126: UniSafe-Product Description 76

Table 127: Pavmed Inc Pipeline Products & Ongoing Clinical Trials Overview 77

Table 128: NextFlo-Product Status 77

Table 129: NextFlo-Product Description 77

Table 130: PRO-IV Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 78

Table 131: Drop Controlling/Counting Valve-Product Status 78

Table 132: Drop Controlling/Counting Valve-Product Description 78

Table 133: Drug Port Verification Valve-Product Status 79

Table 134: Drug Port Verification Valve-Product Description 79

Table 135: Electronic Valve-Product Status 79

Table 136: Electronic Valve-Product Description 79

Table 137: PRIDE System-Product Status 80

Table 138: PRIDE System-Product Description 80

Table 139: Ratio, Inc. Pipeline Products & Ongoing Clinical Trials Overview 81

Table 140: NuPrivo-CI-Product Status 81

Table 141: NuPrivo-CI-Product Description 81

Table 142: Rice University Pipeline Products & Ongoing Clinical Trials Overview 82

Table 143: AutoSyP Syringe Pump-Product Status 82

Table 144: AutoSyP Syringe Pump-Product Description 82

Table 145: SteadyMed Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 83

Table 146: PatchPump-Product Status 83

Table 147: PatchPump-Product Description 84

Table 148: StnDrd Infusion Corporation Pipeline Products & Ongoing Clinical Trials Overview 85

Table 149: Smart Infusion System-Product Status 85

Table 150: Smart Infusion System-Product Description 85

Table 151: StnDrd Pump-Product Status 86

Table 152: StnDrd Pump-Product Description 86

Table 153: Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 87

Table 154: Short Peripheral Infusion Catheter-Product Status 87

Table 155: Short Peripheral Infusion Catheter-Product Description 87

Table 156: Terumo Corporation Pipeline Products & Ongoing Clinical Trials Overview 88

Table 157: Needleless Infusion System-Product Status 88

Table 158: Needleless Infusion System-Product Description 88

Table 159: Terufusion-Product Status 89

Table 160: Terufusion-Product Description 89

Table 161: ToucheMedical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 90

Table 162: Syringe Based Patch Pump-Product Status 90

Table 163: Syringe Based Patch Pump-Product Description 90

Table 164: Unilife Corporation Pipeline Products & Ongoing Clinical Trials Overview 91

Table 165: Unilife AutoInfusor-Product Status 91

Table 166: Unilife AutoInfusor-Product Description 92

Table 167: University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 93

Table 168: Infusion Micropump-Product Status 93

Table 169: Infusion Micropump-Product Description 94

Table 170: University of Southern California Pipeline Products & Ongoing Clinical Trials Overview 95

Table 171: Drug Infusion Pump-Product Status 95

Table 172: Drug Infusion Pump-Product Description 95

Table 173: Glossary 146

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

410 Medical Innovation, LLC

Acuros GmbH

AktiVax Inc.

Alnylam Pharmaceuticals, Inc.

Anesthesia Safety Products, LLC

AngioDynamics, Inc.

Automedics Medical Systems

Baxter International Inc.

BioCardia, Inc.

Debiotech S.A.

Delpor, Inc.

Edwards Lifesciences Corporation

Eksigent Technologies, LLC

Eli Lilly and Company

Flowonix Medical, Inc.

FluidSynchrony, LLC

Fluonic, Inc.

Fresenius Kidney Care

Imagnus Biomedical Inc.

Innovfusion Pte. Ltd.

Intarcia Therapeutics, Inc.

IRadimed Corporation

Ivenix, Inc.

LifeMedix, LLC

Lynntech, Inc.

Medallion Therapeutics, Inc.

Medical Device Creations Ltd.

MedPrime Technologies Pvt. Ltd.

Mercator MedSystems, Inc.

Nano Precision Medical

NexGen Medical Systems, Inc.

Nipro Corporation

Owen Mumford Limited

Pavmed Inc

PRO-IV Medical Ltd.

Ratio, Inc.

Rice University

SteadyMed Therapeutics, Inc.

StnDrd Infusion Corporation

Tel Aviv University

Terumo Corporation

ToucheMedical Ltd.

Unilife Corporation

University of Minnesota

University of Southern California

410 Medical Innovation, LLC, LifeFlow Rapid Infusion System; Acuros GmbH, Disposable Micropump; AktiVax Inc., Immunoject; Alnylam Pharmaceuticals, Inc., ALN-HTT Infusion System; Anesthesia Safety Products, LLC, FloStat Infusion Pump System; AngioDynamics, Inc., BioFlo Portline Line Extension; AngioDynamics, Inc., Next Generation BioFlo Port; AngioDynamics, Inc., Power Injectable Port; AngioDynamics, Inc., Smart Port-Dual; Automedics Medical Systems, AutoHep System; Baxter International Inc., Infusion Pump; BioCardia, Inc., Helix Transendocardial Delivery System; Debiotech S.A., MIP Device; Delpor, Inc., Delpor Microfabricated Nanopore Device; Edwards Lifesciences Corporation, Integrated Semi-Closed Loop System; Eksigent Technologies, LLC, External Drug Delivery System; Eksigent Technologies, LLC, Implantable Drug Delivery System; Eli Lilly and Company, Drug Delivery System-Parkinson's Disease; Flowonix Medical, Inc., Implanted Drug Delivery System; FluidSynchrony, LLC, FluidSync Pump; Fluonic, Inc., SURE+; Fresenius Kidney Care, Intravenous 2008MeDS; Imagnus Biomedical Inc., DeltaFlow Infusion Regulator; Innovfusion Pte. Ltd., DIVA; Innovfusion Pte. Ltd., EPIVA; Innovfusion Pte. Ltd., INTRAVA; Intarcia Therapeutics, Inc., ITCA 638; Intarcia Therapeutics, Inc., ITCA 650 Osmotic Pump; Intarcia Therapeutics, Inc., ITCA 880; IRadimed Corporation, MRidium 3860+ MRI IV Pump; Ivenix, Inc., Next-Generation Infusion Management System; LifeMedix, LLC, STATfusion; Lynntech, Inc., Disposable Drug Infusion Pump; Medallion Therapeutics, Inc., Medallion Infusion System; Medical Device Creations Ltd., Infusion Pump; MedPrime Technologies Pvt. Ltd., InfuCheck; Mercator MedSystems, Inc., Bullfrog Micro-Infusion Device-Below The Knee; Nano Precision Medical, Nano Portal Capsule; NexGen Medical Systems, Inc., PeriCATH; Nipro Corporation, Pump For Venous Anesthesia Infusion; Owen Mumford Limited, UniSafe; Pavmed Inc, NextFlo; PRO-IV Medical Ltd., Drop Controlling/Counting Valve; PRO-IV Medical Ltd., Drug Port Verification Valve; PRO-IV Medical Ltd., Electronic Valve; PRO-IV Medical Ltd., PRIDE System; Ratio, Inc., NuPrivo-CI; Rice University, AutoSyP Syringe Pump; SteadyMed Therapeutics, Inc., PatchPump; StnDrd Infusion Corporation, Smart Infusion System; StnDrd Infusion Corporation, StnDrd Pump; Tel Aviv University, Short Peripheral Infusion Catheter; Terumo Corporation, Needleless Infusion System; Terumo Corporation, Terufusion; ToucheMedical Ltd., Syringe Based Patch Pump; Unilife Corporation, Unilife AutoInfusor; University of Minnesota, Infusion Micropump; University of Southern California, Drug Infusion Pump

select a license
Single User License
USD 4000 INR 287600
Site License
USD 8000 INR 575200
Corporate User License
USD 12000 INR 862800

NEWSLETTER BY CATEGORY




Testimonials

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com